Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2023 for Horizon Therapeutics Public Ltd Co, €846k.
Filing timeline
BuySaleSean M. Clayton
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sean M. Clayton: trading record in brief
This profile gathers the share dealings of Sean M. Clayton in Horizon Therapeutics Public Ltd Co. We count 3 filings; the first trade dates from 4 August 2022 and the latest from 6 October 2023.
Every open-market trade on record is a purchase: 1 purchase worth €48k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise.
The newest entry dates from 6 October 2023: a transaction of €846k, in Horizon Therapeutics Public Ltd Co. The clock since the last published purchase (8 August 2022) now reads 1,538 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sean M. Clayton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
7,655 shares@ US$116.5094.6% of flowOrdinary SharesSEC:0001209191-23-052359:0
14,129 sharesOrdinary SharesSEC:0001209191-23-016347:0
745 shares@ US$66.675.4% of flowOrdinary SharesSEC:0001209191-22-044796:0
Canonical exit: 2 Nov 2022 (T+90)
3 of 3 declarations
